We are live on ! Find out more
CTA

Carillon Tower Advisers Portfolio holdings

AUM $16.4B
1-Year Est. Return 64.75%
This Fund
S&P 500
This Quarter Est. Return
+36.45%
1 Year Est. Return
+64.75%
3 Year Est. Return
+147.06%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$13B
AUM Growth
+$2.78B
Cap. Flow
-$835M
Cap. Flow %
-6.43%
Top 10 Hldgs %
11.13%
Holding
487
New
48
Increased
80
Reduced
272
Closed
26

Top Buys

Rank Stock Value
1
RMD icon
ResMed
RMD
+$52.9M
2
WST icon
West Pharmaceutical
WST
+$39.7M
3
AMED
Amedisys
AMED
+$36.8M
4
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$34M
5
SPOT icon
Spotify
SPOT
+$34M

Top Sells

Rank Stock Value
1
GPN icon
Global Payments
GPN
+$100M
2
CNC icon
Centene
CNC
+$90.3M
3
SBAC icon
SBA Communications
SBAC
+$56.2M
4
HXL icon
Hexcel
HXL
+$45.6M
5
EXAS
Exact Sciences
EXAS
+$44.1M

Sector Composition

Rank Sector Weight
1 Technology 25.62%
2 Healthcare 22.32%
3 Industrials 14.01%
4 Consumer Discretionary 12.64%
5 Financials 7.4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LIND icon
451
Lindblad Expeditions
LIND
$2.17B
$1.27M 0.01%
164,605
-4,500
-3% -$31.1K
GIII icon
452
G-III Apparel Group
GIII
$1.54B
$1.13M 0.01%
85,201
-2,300
-3% -$25.4K
RLGT icon
453
Radiant Logistics
RLGT
$393M
$1.11M 0.01%
283,775
-7,700
-3% -$29.7K
CLB icon
454
Core Laboratories
CLB
$491M
$854K 0.01%
42,007
-742
-2% -$13.3K
IR icon
455
Ingersoll Rand
IR
$34.1B
$819K 0.01%
29,129
-696
-2% -$19.7K
CRS icon
456
Carpenter Technology
CRS
$27B
$777K 0.01%
31,999
-335
-1% -$7.44K
OTIS icon
457
Otis Worldwide
OTIS
$27.5B
$668K 0.01%
+11,750
New +$609K
ACAD icon
458
Acadia Pharmaceuticals
ACAD
$4.39B
– –
-715,382
Closed -$28.1M
ATRA icon
459
Atara Biotherapeutics
ATRA
$77M
– –
-48,810
Closed -$9.49M
BFAM icon
460
Bright Horizons
BFAM
$4.01B
– –
-372,200
Closed -$34.6M
CHE icon
461
Chemed
CHE
$7.07B
– –
-100,708
Closed -$40.3M
COO icon
462
Cooper Companies
COO
$14.5B
– –
-24,720
Closed -$1.7M
DIS icon
463
Walt Disney
DIS
$170B
– –
-22,300
Closed -$2.15M
DLTR icon
464
Dollar Tree
DLTR
$24.9B
– –
-523,508
Closed -$38.2M
EXAS
465
DELISTED
Exact Sciences
EXAS
– –
-788,319
Closed -$44.1M
GCO icon
466
Genesco
GCO
$435M
– –
-456,221
Closed -$5.3M
HAE icon
467
Haemonetics
HAE
$3.94B
– –
-344,772
Closed -$31.6M
MORN icon
468
Morningstar
MORN
$7.46B
– –
-252,885
Closed -$35.7M
NMIH icon
469
NMI Holdings
NMIH
$3.35B
– –
-1,056,822
Closed -$11.5M
NVCR icon
470
NovoCure
NVCR
$1.78B
– –
-572,680
Closed -$36.9M
SRE icon
471
Sempra
SRE
$57.3B
– –
-121,588
Closed -$6.3M
TT icon
472
Trane Technologies
TT
$101B
– –
-32,496
Closed -$2.68M
VLO icon
473
Valero Energy
VLO
$88.5B
– –
-133,850
Closed -$6.07M
WBD icon
474
Warner Bros
WBD
$65.4B
– –
-69,608
Closed -$1.35M
WFC icon
475
Wells Fargo
WFC
$266B
– –
-235,517
Closed -$6.26M
16 17 18
19
20

Similar funds

GAM
Greenwoods Asset Management Grand Cayman, Cayman Islands $4.35B AUM 149.74% 1-Year Est. Return
CCI
Columbus Circle Investors $2.28B AUM 135.57% 1-Year Est. Return
SWM
SVA Wealth Management Madison, Wisconsin $1.15B AUM 22.3% 1-Year Est. Return
LCM
Lomas Capital Management New York $1.04B AUM 24.59% 1-Year Est. Return
HCMNY
Howard Capital Management (New York) New York $891M AUM 34.82% 1-Year Est. Return
BII
Bainco International Investors Boston, Massachusetts $873M AUM 30.2% 1-Year Est. Return
HCM
Horan Capital Management Hunt Valley, Maryland $794M AUM 30.86% 1-Year Est. Return
DBC
Deep Basin Capital Stamford, Connecticut $739M AUM 4.75% 1-Year Est. Return

Carillon Tower Advisers's Q2 2020 Portfolio in Review

As of Q2 2020, Carillon Tower Advisers held 487 positions worth $13B, up 27% from $10.2B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Carillon Tower Advisers withdrew a net $835M in Q2 2020, closing 26 positions and reducing 272 holdings. Its most notable exit was Exact Sciences, an estimated $44.1M position sold in full.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 24% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Carillon Tower Advisers opened a new position in ResMed worth $62M.

  • Carillon Tower Advisers's largest Q2 2020 buy was ResMed: 323,155 shares worth $62M.
  • Carillon Tower Advisers added most to Amedisys in Q2 2020, an estimated $36.8M increase.
  • Carillon Tower Advisers's biggest Q2 2020 reduction was Global Payments, cutting an estimated $100M.
  • Carillon Tower Advisers fully exited Exact Sciences in Q2 2020, selling an estimated $44.1M.
  • Carillon Tower Advisers's ten largest holdings make up 11% of its $13B portfolio in Q2 2020.
  • Carillon Tower Advisers opened 48 new positions and closed 26 in Q2 2020.
  • Carillon Tower Advisers's portfolio value rose 27% quarter-over-quarter to $13B.

Based on Carillon Tower Advisers's 13F filing for Q2 2020, filed 12 Aug 2020.